References
Stanford, S. M. et al. Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase. Nat. Chem. Biol. http://dx.doi.org/10.1038/nchembio.2344 (2017)
Rights and permissions
About this article
Cite this article
Crunkhorn, S. Protein tyrosine phosphatase inhibitor reverses diabetes. Nat Rev Drug Discov 16, 312–313 (2017). https://doi.org/10.1038/nrd.2017.73
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2017.73
- Springer Nature Limited
This article is cited by
-
Protein tyrosine phosphatases (PTPs) in diabetes: causes and therapeutic opportunities
Archives of Pharmacal Research (2021)
-
PRL-2 phosphatase is required for vascular morphogenesis and angiogenic signaling
Communications Biology (2020)